304 related articles for article (PubMed ID: 33684466)
1. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; GÅ‚ogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against
Nandikolla A; Khetmalis YM; Venkata Siva Kumar B; Chandu A; Karan Kumar B; Shetye G; Ma R; Murugesan S; Franzblau SG; Chandra Sekhar KVG
RSC Med Chem; 2023 Aug; 14(8):1549-1561. PubMed ID: 37593576
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203.
Kang S; Kim YM; Kim RY; Seo MJ; No Z; Nam K; Kim S; Kim J
Eur J Med Chem; 2017 Jan; 125():807-815. PubMed ID: 27750198
[TBL] [Abstract][Full Text] [Related]
6. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
Moraski GC; Oliver AG; Markley LD; Cho S; Franzblau SG; Miller MJ
Bioorg Med Chem Lett; 2014 Aug; 24(15):3493-8. PubMed ID: 24909079
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV
Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-
Khetmalis YM; Chitti S; Umarani Wunnava A; Karan Kumar B; Murali Krishna Kumar M; Murugesan S; Chandra Sekhar KVG
RSC Med Chem; 2022 Mar; 13(3):327-342. PubMed ID: 35434623
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K
Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and In Vitro Biological Evaluation of Pyridine, Thiadazole, Benzimidazole and Acetyl Thiophene Analogues as Anti Tubercular Agents Targeting Enzyme Inh A.
Suresh AJ; Nandini S; Sangeetha K; Dhivya LS; Surya PR
Curr Comput Aided Drug Des; 2021; 17(6):773-784. PubMed ID: 32713342
[TBL] [Abstract][Full Text] [Related]
12. Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives.
Naidu KM; Srinivasarao S; Agnieszka N; Ewa AK; Kumar MM; Chandra Sekhar KV
Bioorg Med Chem Lett; 2016 May; 26(9):2245-50. PubMed ID: 27020525
[TBL] [Abstract][Full Text] [Related]
13. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
15. 2-Butyl-4-chloroimidazole based substituted piperazine-thiosemicarbazone hybrids as potent inhibitors of Mycobacterium tuberculosis.
Jallapally A; Addla D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Dec; 24(23):5520-4. PubMed ID: 25451998
[TBL] [Abstract][Full Text] [Related]
16. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y
Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507
[TBL] [Abstract][Full Text] [Related]
18. Click chemistry based regioselective one-pot synthesis of coumarin-3-yl-methyl-1,2,3-triazolyl-1,2,4-triazol-3(4H)-ones as newer potent antitubercular agents.
Somagond SM; Kamble RR; Bayannavar PK; Shaikh SKJ; Joshi SD; Kumbar VM; Nesaragi AR; Kariduraganavar MY
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900013. PubMed ID: 31397503
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione.
Khan IH; Patel NB; Patel VM
Curr Comput Aided Drug Des; 2018; 14(4):269-283. PubMed ID: 29766819
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis.
Rode ND; Sonawane AD; Nawale L; Khedkar VM; Joshi RA; Likhite AP; Sarkar D; Joshi RR
Chem Biol Drug Des; 2017 Dec; 90(6):1206-1214. PubMed ID: 28609019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]